{"Abstract": [0], "Gastric": [1], "cancer": [2, 21, 73, 92], "is": [3, 63, 74, 97], "not": [4], "a": [5, 80], "top\u201010": [6], "malignancy": [7], "in": [8, 57, 105], "the": [9, 16, 35, 138, 156], "United": [10], "States": [11], "but": [12], "represents": [13], "one": [14], "of": [15, 20, 37, 82, 90, 140, 161, 168], "most": [17, 142], "common": [18], "causes": [19], "death": [22, 112], "worldwide.": [23], "Biological": [24], "differences": [25], "between": [26], "tumors": [27], "from": [28, 146], "Eastern": [29], "and": [30, 50, 77, 126, 135, 148, 164], "Western": [31], "countries": [32], "add": [33], "to": [34, 65, 144], "complexity": [36], "identifying": [38], "standard\u2010of\u2010care": [39], "therapy": [40, 52, 133], "based": [41, 93], "on": [42, 94], "international": [43], "trials.": [44], "Systemic": [45], "chemotherapy,": [46], "radiotherapy,": [47], "surgery,": [48], "immunotherapy,": [49], "targeted": [51, 149], "all": [53], "have": [54], "proven": [55], "efficacy": [56], "gastric": [58, 72, 91, 162], "adenocarcinoma;": [59], "therefore,": [60], "multidisciplinary": [61], "treatment": [62, 66], "paramount": [64], "selection.": [67], "Triplet": [68], "chemotherapy": [69, 85], "for": [70, 86, 101, 137, 155], "resectable": [71], "now": [75], "accepted": [76], "could": [78], "represent": [79], "plateau": [81], "standard": [83], "cytotoxic": [84], "localized": [87], "disease.": [88], "Classification": [89], "molecular": [95], "subtypes": [96, 160], "providing": [98], "an": [99], "opportunity": [100], "personalized": [102], "therapy.": [103, 150], "Biomarkers,": [104], "particular": [106], "microsatellite": [107], "instability": [108], "(MSI),": [109], "programmed": [110], "cell": [111], "ligand": [113], "1": [114], "(PD\u2010L1),": [115], "human": [116], "epidermal": [117], "growth": [118], "factor": [119], "receptor": [120], "2": [121], "(HER2),": [122], "tumor": [123], "mutation": [124], "burden,": [125], "Epstein\u2010Barr": [127], "virus,": [128], "are": [129], "increasingly": [130], "driving": [131], "systemic": [132], "approaches": [134], "allowing": [136], "identification": [139], "populations": [141], "likely": [143], "benefit": [145], "immunotherapy": [147, 169], "Significant": [151], "research": [152], "opportunities": [153], "remain": [154], "less": [157], "differentiated": [158], "histologic": [159], "adenocarcinoma": [163], "those": [165], "without": [166], "markers": [167], "activity.": [170]}